Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / RYTM - Rhythm Pharma's setmelanotide shows positive action in mid-stage obesity study

RYTM - Rhythm Pharma's setmelanotide shows positive action in mid-stage obesity study

Rhythm Pharmaceuticals Inc.
  • Rhythm Pharmaceuticals (NASDAQ:RYTM) announces positive preliminary results from an ongoing Phase 2 clinical trial evaluating setmelanotide in patients with a rare inherited metabolic disorder called melanocortin-4 receptor (MC4R) pathway heterozygous (HET) obesity.
  • More news on: Rhythm Pharmaceuticals, Inc., Healthcare stocks news,
    • Read more ...
Stock Information
Company Name: Rhythm Pharmaceuticals Inc.
Stock Symbol: RYTM
Market: NASDAQ
Website: rhythmtx.com
Menu
RYTM RYTM Quote RYTM Short RYTM News RYTM Articles RYTM Message Board
Get RYTM Alerts

News, Short Squeeze, Breakout and More Instantly...